Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "OPUVIZ"

1 News Found

Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe
News | June 01, 2026

Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe

The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments